136 related articles for article (PubMed ID: 15256524)
1. Case-control study of genotypes in multiple chemical sensitivity: CYP2D6, NAT1, NAT2, PON1, PON2 and MTHFR.
McKeown-Eyssen G; Baines C; Cole DE; Riley N; Tyndale RF; Marshall L; Jazmaji V
Int J Epidemiol; 2004 Oct; 33(5):971-8. PubMed ID: 15256524
[TBL] [Abstract][Full Text] [Related]
2. Sequence variations in subjects with self-reported multiple chemical sensitivity (sMCS): a case-control study.
Wiesmüller GA; Niggemann H; Weissbach W; Riley F; Maarouf Z; Dott W; Kunert HJ; Zerres K; Eggermann T; Blömeke B
J Toxicol Environ Health A; 2008; 71(11-12):786-94. PubMed ID: 18569577
[TBL] [Abstract][Full Text] [Related]
3. No association between genetic polymorphisms in NAD(P)H oxidase p22phox and paraoxonase 1 and colorectal cancer risk.
Van Der Logt EM; Janssen CH; Van Hooijdonk Z; Roelofs HM; Wobbes T; Nagengast FM; Peters WH
Anticancer Res; 2005; 25(2B):1465-70. PubMed ID: 15865106
[TBL] [Abstract][Full Text] [Related]
4. Genetic susceptibility factors for multiple chemical sensitivity revisited.
Berg ND; Rasmussen HB; Linneberg A; Brasch-Andersen C; Fenger M; Dirksen A; Vesterhauge S; Werge T; Elberling J
Int J Hyg Environ Health; 2010 Mar; 213(2):131-9. PubMed ID: 20185366
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphism of CYP2D6 influences susceptibility to papillary thyroid cancer.
Lemos MC; Carrilho F; Rodrigues F; Coutinho E; Gomes L; Carvalheiro M; Regateiro FJ
Clin Endocrinol (Oxf); 2007 Aug; 67(2):180-3. PubMed ID: 17547692
[TBL] [Abstract][Full Text] [Related]
6. CYP2D6 genetic polymorphisms are associated with susceptibility to pituitary tumors.
Gomes L; Lemos MC; Paiva I; Ribeiro C; Carvalheiro M; Regateiro FJ
Acta Med Port; 2005; 18(5):339-43. PubMed ID: 16611538
[TBL] [Abstract][Full Text] [Related]
7. Xenobiotic gene polymorphisms and susceptibility to multiple myeloma.
Lincz LF; Kerridge I; Scorgie FE; Bailey M; Enno A; Spencer A
Haematologica; 2004 May; 89(5):628-9. PubMed ID: 15136237
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
[TBL] [Abstract][Full Text] [Related]
9. Human paraoxonase gene polymorphisms and coronary artery disease risk.
Mendonça MI; Dos Reis RP; Freitas AI; Sousa AC; Pereira A; Faria P; Gomes S; Silva B; Santos N; Serrão M; Ornelas I; Freitas S; Araújo JJ; Brehm A; Cardoso AA
Rev Port Cardiol; 2008 Dec; 27(12):1539-55. PubMed ID: 19280995
[TBL] [Abstract][Full Text] [Related]
10. Biological definition of multiple chemical sensitivity from redox state and cytokine profiling and not from polymorphisms of xenobiotic-metabolizing enzymes.
De Luca C; Scordo MG; Cesareo E; Pastore S; Mariani S; Maiani G; Stancato A; Loreti B; Valacchi G; Lubrano C; Raskovic D; De Padova L; Genovesi G; Korkina LG
Toxicol Appl Pharmacol; 2010 Nov; 248(3):285-92. PubMed ID: 20430047
[TBL] [Abstract][Full Text] [Related]
11. Reduced CYP2D6 activity is a negative risk factor for methamphetamine dependence.
Otani K; Ujike H; Sakai A; Okahisa Y; Kotaka T; Inada T; Harano M; Komiyama T; Hori T; Yamada M; Sekine Y; Iwata N; Iyo M; Sora I; Ozaki N; Kuroda S
Neurosci Lett; 2008 Mar; 434(1):88-92. PubMed ID: 18280655
[TBL] [Abstract][Full Text] [Related]
12. Role of genetic polymorphisms of CYP1A1, CYP3A5, CYP2C9, CYP2D6, and PON1 in the modulation of DNA damage in workers occupationally exposed to organophosphate pesticides.
Singh S; Kumar V; Vashisht K; Singh P; Banerjee BD; Rautela RS; Grover SS; Rawat DS; Pasha ST; Jain SK; Rai A
Toxicol Appl Pharmacol; 2011 Nov; 257(1):84-92. PubMed ID: 21907728
[TBL] [Abstract][Full Text] [Related]
13. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias.
Aydin-Sayitoglu M; Hatirnaz O; Erensoy N; Ozbek U
Am J Hematol; 2006 Mar; 81(3):162-70. PubMed ID: 16493615
[TBL] [Abstract][Full Text] [Related]
14. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke.
Can Demirdöğen B; Türkanoğlu A; Bek S; Sanisoğlu Y; Demirkaya S; Vural O; Arinç E; Adali O
Clin Biochem; 2008 Jan; 41(1-2):1-9. PubMed ID: 17920578
[TBL] [Abstract][Full Text] [Related]
15. Relation of PON1 and CYP1A1 genetic polymorphisms to clinical findings in a cross-sectional study of a Greek rural population professionally exposed to pesticides.
Tsatsakis AM; Zafiropoulos A; Tzatzarakis MN; Tzanakakis GN; Kafatos A
Toxicol Lett; 2009 Apr; 186(1):66-72. PubMed ID: 19022366
[TBL] [Abstract][Full Text] [Related]
16. 192R allele of paraoxanase 1 (PON1) gene as a new marker for susceptibility to bladder cancer.
Oztürk O; Kağnici OF; Oztürk T; Durak H; Tüzüner BM; Kisakesen HI; Cakalir C; Isbir T
Anticancer Res; 2009 Oct; 29(10):4041-6. PubMed ID: 19846948
[TBL] [Abstract][Full Text] [Related]
17. [Genetic polymorphism of CYP-1A1, CYP2D6 and risks of chronic benzene poisoning].
Gu SY; Zhang ZB; Cao DZ; Wan JX; Gao XL; Jin XP; Xia ZL
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 May; 24(5):266-9. PubMed ID: 16737584
[TBL] [Abstract][Full Text] [Related]
18. Age and hypertension related changes in genotypes of MTHFR 677C>T, 1298A>C and PON1 -108C>T SNPs in men with coronary artery disease (CAD).
Strauss E; Głuszek J; Pawlak AL
J Physiol Pharmacol; 2005 Mar; 56 Suppl 2():65-75. PubMed ID: 16077191
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility.
Chen HC; Hu WX; Liu QX; Li WK; Chen FZ; Rao ZZ; Liu XF; Luo YP; Cao YF
Eur J Cancer Prev; 2008 Jun; 17(3):251-8. PubMed ID: 18414197
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphism of CYP2D6 in patients with cardiovascular disease -- a cohort study.
Teh LK; Zilfalil BA; Marina I; Rosemi BS; Ismail R
J Clin Pharm Ther; 2004 Dec; 29(6):559-64. PubMed ID: 15584944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
